Daniel Sundheim’s Outset Medical OM Stock Holding History

Daniel Sundheim’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-305,050	Closed	-$226M	–	58
2021 Q3	$226M	Hold	305,050	–	–	1.26%	25
2021 Q2	$229M	Hold	305,050	–	–	1.5%	21
2021 Q1	$249M	Hold	305,050	–	–	1.84%	19
2020 Q4	$260M	Hold	305,050	–	–	1.23%	25
2020 Q3	$229M	Buy	+305,050	New	+$251M	1.34%	26

Other funds holding OM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Daniel Sundheim's OM Position: Q4 2021 in Review

Daniel Sundheim sold out of Outset Medical (OM) in Q4 2021, closing a stake of 305,050 shares — an estimated $226M sold.

Daniel Sundheim first reported a position in OM in Q3 2020 and held it in 5 quarters. The position peaked at $260M in Q4 2020. 156 funds tracked by Wall St. Rank hold OM as of Q4 2021.

Daniel Sundheim reported no remaining Outset Medical position as of Q4 2021 after selling out during the quarter.
Daniel Sundheim sold 305,050 Outset Medical shares in Q4 2021, an estimated $226M.
Daniel Sundheim first reported a position in Outset Medical in Q3 2020 and held it in 5 quarters.
Daniel Sundheim's Outset Medical position peaked at $260M in Q4 2020.
156 funds tracked by Wall St. Rank held Outset Medical as of Q4 2021.

Based on D1 Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.